These results suggest that the key factors for the therapeutic effect of serum are the incoming component of DM rather than the serum itself, and the possible involvement of PPARγ in the treatment of DM in serum, which is consistent with bioinformatics analysis and animal experimental investigations. The gene discussed is PPARG; the disease is diabetes mellitus.